These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO. Kim M; Tomek P Front Immunol; 2021; 12():636081. PubMed ID: 33708223 [TBL] [Abstract][Full Text] [Related]
3. Tryptophan Catabolism and Cancer Immunotherapy Targeting IDO Mediated Immune Suppression. Amobi A; Qian F; Lugade AA; Odunsi K Adv Exp Med Biol; 2017; 1036():129-144. PubMed ID: 29275469 [TBL] [Abstract][Full Text] [Related]
4. Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism. Li Y; Hu N; Yang D; Oxenkrug G; Yang Q FEBS J; 2017 Mar; 284(6):948-966. PubMed ID: 28118532 [TBL] [Abstract][Full Text] [Related]
5. Role of tryptophan metabolism in cancers and therapeutic implications. Liu XH; Zhai XY Biochimie; 2021 Mar; 182():131-139. PubMed ID: 33460767 [TBL] [Abstract][Full Text] [Related]
6. Systemic tryptophan homeostasis. Klaessens S; Stroobant V; De Plaen E; Van den Eynde BJ Front Mol Biosci; 2022; 9():897929. PubMed ID: 36188218 [TBL] [Abstract][Full Text] [Related]
7. IL4i1 and IDO1: Oxidases that control a tryptophan metabolic nexus in cancer. Zeitler L; Murray PJ J Biol Chem; 2023 Jun; 299(6):104827. PubMed ID: 37196768 [TBL] [Abstract][Full Text] [Related]
8. Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system. Ala M Int Rev Immunol; 2022; 41(3):326-345. PubMed ID: 34289794 [TBL] [Abstract][Full Text] [Related]
9. Heme-containing enzymes and inhibitors for tryptophan metabolism. Yan D; Lin YW; Tan X Metallomics; 2017 Sep; 9(9):1230-1240. PubMed ID: 28650043 [TBL] [Abstract][Full Text] [Related]
10. Role of indoleamine 2,3-dioxygenase in health and disease. Yeung AW; Terentis AC; King NJ; Thomas SR Clin Sci (Lond); 2015 Oct; 129(7):601-72. PubMed ID: 26186743 [TBL] [Abstract][Full Text] [Related]
11. Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. MacKenzie CR; Heseler K; Müller A; Däubener W Curr Drug Metab; 2007 Apr; 8(3):237-44. PubMed ID: 17430112 [TBL] [Abstract][Full Text] [Related]
12. In vitro rescue of genital strains of Chlamydia trachomatis from interferon-γ and tryptophan depletion with indole-positive, but not indole-negative Prevotella spp. Ziklo N; Huston WM; Taing K; Katouli M; Timms P BMC Microbiol; 2016 Dec; 16(1):286. PubMed ID: 27914477 [TBL] [Abstract][Full Text] [Related]
13. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. Platten M; Wick W; Van den Eynde BJ Cancer Res; 2012 Nov; 72(21):5435-40. PubMed ID: 23090118 [TBL] [Abstract][Full Text] [Related]
14. The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment. Gostner JM; Becker K; Überall F; Fuchs D Expert Opin Ther Targets; 2015 May; 19(5):605-15. PubMed ID: 25684107 [TBL] [Abstract][Full Text] [Related]
15. Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells. Bhutia YD; Babu E; Ganapathy V Biochim Biophys Acta; 2015 Feb; 1848(2):453-62. PubMed ID: 25450809 [TBL] [Abstract][Full Text] [Related]
16. The interplay between metabolic remodeling and immune regulation in glioblastoma. Kesarwani P; Kant S; Prabhu A; Chinnaiyan P Neuro Oncol; 2017 Oct; 19(10):1308-1315. PubMed ID: 28541512 [TBL] [Abstract][Full Text] [Related]
17. The expanding roles of 1-methyl-tryptophan (1-MT): in addition to inhibiting kynurenine production, 1-MT activates the synthesis of melatonin in skin cells. Moreno AC; Clara RO; Coimbra JB; Júlio AR; Albuquerque RC; Oliveira EM; Maria-Engler SS; Campa A FEBS J; 2013 Oct; 280(19):4782-92. PubMed ID: 23879623 [TBL] [Abstract][Full Text] [Related]